Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue May 2015
 •  US Economy Slips in Q1  •  Gojo To Expand Footprint  •  "Break Up with Your Makeup"  •  Ulta Posts Strong Q1  •  Fortunate Ones
Print

SkinMedica: Mary M. Fisher



Published June 23, 2008
Related Searches: system men strategic form
Post a comment
SkinMedica:
has appointed Mary M. Fisher as chief executive officer. Ms. Fisher was previously chief operating officer at Acorda Therapeutics, a biotechnology company focused on developing products for the treatment of central nervous system disorders. During her seven years at Acorda, she also served as executive vice president of commercial operations and vice president of marketing and strategic planning. As chief operating officer, she played a key role in Acorda’s success, including its successful IPO and the subsequent strong operating performance and impressive growth in shareholder value. Prior to Acorda, Ms. Fisher was vice president of commercial operations with Cephalon. Her earlier career includes positions with Immunex and Boehringer Ingelheim.


blog comments powered by Disqus